Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) has declared a quarterly dividend of $0.75 per share, payable on April 28, 2023, to shareholders on record as of March 31, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Stryker (NYSE:SYK) has declared a quarterly dividend of $0.75 per share, payable on April 28, 2023, to shareholders on record as of March 31, 2023. This dividend reflects a 7.9% increase compared to the previous year, although it remains unchanged from the last quarter. As a leading medical technology company, Stryker aims to enhance healthcare outcomes globally, impacting over 130 million patients annually with its innovative medical products and services across various sectors including neurotechnology, orthopaedics, and spine.
Positive
- Quarterly dividend increased by 7.9% compared to the prior year, indicating strong financial health.
- Dividend amount of $0.75 per share reflects commitment to returning value to shareholders.
Negative
- None.
Details
News Market Reaction – SYK
The recorded move for SYK in the trading session of this news was -1.44%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Kalamazoo Michigan,, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries please contact:
Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.